HK2: A Promising Drug Target / Biomarker (G3099)

Target Name: HK2

NCBI ID: G3099

Content of Review Report on HK2 Target / Biomarker

HK2

HK2: A Promising Drug Target / Biomarker

HK2 is a protein that is expressed in the human placenta and has been shown to play a role in pregnancy outcomes. Studies have shown that levels of HK2 have been significantly decreased in women with preterm labor and that higher levels of HK2 are associated with increased risk of preterm birth. This has led researchers to investigate the potential therapeutic benefits of targeting HK2 as a drug target or biomarker. In this article, we will explore the science behind HK2 and the potential implications of targeting it as a drug target or biomarker.

The Science Behind HK2

HK2, or human placenta-derived microRNA-221, is a non-coding RNA molecule that is produced by the placenta during pregnancy. It is expressed in the placenta and has been shown to play a role in regulating various physiological processes that are critical for fetal development and growth.

One of the key functions of HK2 is its role in regulating the expression of genes that are involved in cell adhesion and migration. This is important for the development and growth of the placenta, which is the vital source of nutrients and oxygen for the developing fetus.

In addition to its role in gene regulation, HK2 has also been shown to play a role in the regulation of cellular processes that are critical for the development and growth of the fetal brain. This is important for the development of the fetal nervous system and the development of the baby's first thoughts and emotions.

The Potential Implications of Targeting HK2

HK2 has been shown to be involved in the regulation of a wide range of physiological processes that are critical for fetal development and growth. As such, targeting HK2 as a drug target or biomarker has the potential to revolutionize our understanding of pregnancy and fetal development.

One of the key potential benefits of targeting HK2 is its potential to treat a wide range of pregnancy-related conditions, including preterm labor. Studies have shown that levels of HK2 have been significantly decreased in women with preterm labor and that higher levels of HK2 are associated with increased risk of preterm birth. By targeting HK2, researchers may be able to develop new treatments for preterm labor that can improve outcomes for women.

Another potential benefit of targeting HK2 is its potential to treat other pregnancy-related conditions, including low birth weight. Studies have shown that levels of HK2 have been significantly decreased in women with low birth weight and that higher levels of HK2 are associated with increased risk of low birth weight. By targeting HK2, researchers may be able to develop new treatments for low birth weight that can improve outcomes for women.

Targeting HK2 as a drug target or biomarker also has the potential to improve our understanding of the underlying mechanisms that regulate the expression of HK2 during pregnancy. This is important for the development of new treatments that are based on a better understanding of the underlying mechanisms that regulate HK2.

Conclusion

HK2 is a protein that is expressed in the human placenta and has been shown to play a role in pregnancy outcomes. Studies have shown that levels of HK2 have been significantly decreased in women with preterm labor and that higher levels of HK2 are associated with increased risk of preterm birth. As such, targeting HK2 as a drug target or biomarker has the potential to revolutionize our understanding of pregnancy and fetal development. By targeting HK2, researchers may be able to develop new treatments for preterm labor and low birth weight that can improve outcomes for women.

Protein Name: Hexokinase 2

Functions: Catalyzes the phosphorylation of hexose, such as D-glucose and D-fructose, to hexose 6-phosphate (D-glucose 6-phosphate and D-fructose 6-phosphate, respectively) (PubMed:23185017, PubMed:26985301, PubMed:29298880). Mediates the initial step of glycolysis by catalyzing phosphorylation of D-glucose to D-glucose 6-phosphate (PubMed:29298880). Plays a key role in maintaining the integrity of the outer mitochondrial membrane by preventing the release of apoptogenic molecules from the intermembrane space and subsequent apoptosis (PubMed:18350175)

The "HK2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HK2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets